Keywords: fast-track, review, isis, antisense, drug, bayer, corp

Fast-track review for Isis

Article | 15 November 2000

Print This

Bayer Corp has submitted a regulatory dossier to the US Food and DrugAdministration seeking approval to market an intravenous formulation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in